DDOG vs DHR: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Danaher Corporation โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Datadog, Inc. ยท Technology
$256.92
+28.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Danaher Corporation ยท Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
DDOG |
DHR |
| Current Price |
$256.92 |
$221.12 |
| Fair Value Estimate |
$330.72 |
$286.52 |
| Upside to Fair Value |
+28.7%
|
+29.6%
|
| Market Cap |
$91.5B |
$155.4B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
350.6x
|
24.8x
|
| Price / Sales |
23.1x
|
6.2x
|
| Price / FCF |
78.9x
|
28.5x
|
| Revenue Growth YoY |
+35.6%
|
+5.5%
|
| Gross Margin |
79.5%
|
58.5%
|
| Operating Margin |
0.4%
|
20.4%
|
| Return on Equity |
4.6%
|
7.7%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
1.27%
|
3.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Datadog is a cloud observability platform that unifies infrastructure monitoring, application performance management, log management, security, and incident response into a single SaaS offering used by developers and IT operations teams across North America and internationally. The business quality is high on the top line: revenue grew 35.6% year over year in the most recent quarter, TTM gross maโฆ
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is highโฆ
Accumulation Zones
| Metric |
DDOG |
DHR |
| Zone Low |
$248.04 |
$214.89 |
| Zone High |
$281.11 |
$243.54 |
| In Buy Zone? |
Yes
|
Yes
|